Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxysterols | 2 | 2023 | 7 | 1.510 |
Why?
|
| Cholesterol, Dietary | 2 | 2023 | 29 | 1.500 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 5 | 2023 | 69 | 0.970 |
Why?
|
| Obstetric Labor, Premature | 2 | 2018 | 31 | 0.670 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 1008 | 0.600 |
Why?
|
| Uterus | 1 | 2018 | 41 | 0.550 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2019 | 241 | 0.490 |
Why?
|
| Interleukin-5 | 1 | 2016 | 37 | 0.480 |
Why?
|
| Fetal Diseases | 1 | 2016 | 22 | 0.480 |
Why?
|
| Gastroschisis | 1 | 2016 | 4 | 0.480 |
Why?
|
| Interferon-gamma | 1 | 2018 | 574 | 0.470 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 604 | 0.450 |
Why?
|
| Intestines | 1 | 2016 | 181 | 0.430 |
Why?
|
| Interleukin-17 | 3 | 2020 | 99 | 0.420 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2012 | 299 | 0.400 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2012 | 9 | 0.370 |
Why?
|
| Flow Cytometry | 2 | 2016 | 663 | 0.350 |
Why?
|
| Cell Lineage | 3 | 2019 | 282 | 0.300 |
Why?
|
| Mice | 10 | 2023 | 11119 | 0.300 |
Why?
|
| Umbilical Cord | 2 | 2020 | 9 | 0.280 |
Why?
|
| Inflammation | 4 | 2023 | 1192 | 0.250 |
Why?
|
| alpha-Thalassemia | 1 | 2026 | 2 | 0.250 |
Why?
|
| Pregnancy | 5 | 2026 | 2372 | 0.230 |
Why?
|
| Animals | 11 | 2023 | 21345 | 0.230 |
Why?
|
| Adenosine Triphosphate | 3 | 2012 | 301 | 0.230 |
Why?
|
| Cell Differentiation | 4 | 2020 | 1386 | 0.200 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2026 | 353 | 0.200 |
Why?
|
| Fetus | 2 | 2026 | 102 | 0.190 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 94 | 0.180 |
Why?
|
| Skin | 2 | 2023 | 422 | 0.180 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2023 | 138 | 0.180 |
Why?
|
| Autoantigens | 2 | 2020 | 139 | 0.170 |
Why?
|
| Cholesterol | 1 | 2022 | 261 | 0.170 |
Why?
|
| Fetal Blood | 2 | 2020 | 73 | 0.160 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2020 | 14 | 0.160 |
Why?
|
| Chorioamnionitis | 1 | 2020 | 15 | 0.160 |
Why?
|
| Dermatitis, Atopic | 1 | 2020 | 29 | 0.150 |
Why?
|
| Cell Cycle | 2 | 2012 | 398 | 0.150 |
Why?
|
| SOXC Transcription Factors | 1 | 2018 | 9 | 0.140 |
Why?
|
| Thymocytes | 1 | 2018 | 23 | 0.140 |
Why?
|
| Natural Killer T-Cells | 1 | 2018 | 30 | 0.140 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2293 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 414 | 0.140 |
Why?
|
| Mice, Knockout | 4 | 2020 | 2157 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 312 | 0.140 |
Why?
|
| Infant, Newborn | 3 | 2020 | 1422 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 3485 | 0.140 |
Why?
|
| Calcium Signaling | 1 | 2018 | 164 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 281 | 0.120 |
Why?
|
| Erythroid Cells | 1 | 2016 | 13 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2018 | 3153 | 0.120 |
Why?
|
| Fetal Therapies | 1 | 2016 | 2 | 0.120 |
Why?
|
| Chemokine CCL11 | 1 | 2016 | 4 | 0.120 |
Why?
|
| Amniotic Fluid | 1 | 2016 | 8 | 0.120 |
Why?
|
| Eosinophils | 1 | 2016 | 49 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2016 | 37 | 0.120 |
Why?
|
| Humans | 10 | 2026 | 65140 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2016 | 209 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 217 | 0.100 |
Why?
|
| Obesity | 1 | 2022 | 1274 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2016 | 284 | 0.100 |
Why?
|
| Mothers | 1 | 2016 | 280 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 641 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2012 | 104 | 0.090 |
Why?
|
| Cytokines | 1 | 2016 | 952 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2018 | 713 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 676 | 0.090 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2011 | 9 | 0.080 |
Why?
|
| Female | 5 | 2026 | 34018 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 868 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 237 | 0.080 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 133 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 221 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2009 | 117 | 0.070 |
Why?
|
| Phenotype | 1 | 2012 | 1233 | 0.070 |
Why?
|
| Gestational Age | 2 | 2020 | 193 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2188 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 563 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2009 | 351 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 790 | 0.050 |
Why?
|
| Streptococcus mitis | 1 | 2020 | 1 | 0.040 |
Why?
|
| Ureaplasma | 1 | 2020 | 2 | 0.040 |
Why?
|
| Neonatal Sepsis | 1 | 2020 | 4 | 0.040 |
Why?
|
| Mycoplasma | 1 | 2020 | 6 | 0.040 |
Why?
|
| Adult | 3 | 2026 | 17358 | 0.040 |
Why?
|
| Interleukins | 1 | 2020 | 88 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2020 | 72 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2020 | 241 | 0.040 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2018 | 9 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 112 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2018 | 194 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 105 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 4809 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 753 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 160 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2010 | 742 | 0.030 |
Why?
|
| Term Birth | 1 | 2016 | 6 | 0.030 |
Why?
|
| Receptors, Transferrin | 1 | 2016 | 33 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 852 | 0.030 |
Why?
|
| Cell Separation | 1 | 2016 | 147 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2026 | 5792 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 342 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1290 | 0.030 |
Why?
|
| Transcriptome | 1 | 2018 | 399 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 794 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2620 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2019 | 827 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1480 | 0.020 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 7 | 0.020 |
Why?
|
| Purinergic P2X Receptor Antagonists | 1 | 2010 | 7 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2010 | 30 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2010 | 98 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 434 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2009 | 101 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2009 | 541 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 710 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1038 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1589 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 907 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 663 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1630 | 0.010 |
Why?
|